Cargando…
The Cocrystal of Ubiquinol: Improved Stability and Bioavailability
Coenzyme Q10 (CoQ10) exists in two forms, an oxidized form and a reduced form. Ubiquinol is the fully reduced form of CoQ10. Compared to the oxidized form, ubiquinol has a much higher biological absorption and better therapeutic effect. However, ubiquinol has an important stability problem which ham...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610044/ https://www.ncbi.nlm.nih.gov/pubmed/37896258 http://dx.doi.org/10.3390/pharmaceutics15102499 |
_version_ | 1785128157993500672 |
---|---|
author | Zhang, Qi Xia, Mengyuan Zheng, Chenxuan Yang, Yinghong Bao, Junjie Dai, Wenjuan Mei, Xuefeng |
author_facet | Zhang, Qi Xia, Mengyuan Zheng, Chenxuan Yang, Yinghong Bao, Junjie Dai, Wenjuan Mei, Xuefeng |
author_sort | Zhang, Qi |
collection | PubMed |
description | Coenzyme Q10 (CoQ10) exists in two forms, an oxidized form and a reduced form. Ubiquinol is the fully reduced form of CoQ10. Compared to the oxidized form, ubiquinol has a much higher biological absorption and better therapeutic effect. However, ubiquinol has an important stability problem which hampers its storage and formulation. It can be easily transformed into its oxidized form—ubiquinone—even at low temperature. In this work, we designed, synthesized, and characterized a new cocrystal of ubiquinol with vitamin B3 nicotinamide (UQ-NC). Compared to the marketed ubiquinol form, the cocrystal exhibited an excellent stability, improved dissolution properties, and higher bioavailability. The cocrystal remained stable for a long period, even when stored under stressed conditions. In the dissolution experiments, the cocrystal generated 12.6 (in SIF) and 38.3 (in SGF) times greater maximum ubiquinol concentrations above that of the marketed form. In addition, in the PK studies, compared to the marketed form, the cocrystal exhibited a 2.2 times greater maximum total coenzyme Q10 concentration and a 4.5 times greater AUC than that of the marketed form. |
format | Online Article Text |
id | pubmed-10610044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106100442023-10-28 The Cocrystal of Ubiquinol: Improved Stability and Bioavailability Zhang, Qi Xia, Mengyuan Zheng, Chenxuan Yang, Yinghong Bao, Junjie Dai, Wenjuan Mei, Xuefeng Pharmaceutics Article Coenzyme Q10 (CoQ10) exists in two forms, an oxidized form and a reduced form. Ubiquinol is the fully reduced form of CoQ10. Compared to the oxidized form, ubiquinol has a much higher biological absorption and better therapeutic effect. However, ubiquinol has an important stability problem which hampers its storage and formulation. It can be easily transformed into its oxidized form—ubiquinone—even at low temperature. In this work, we designed, synthesized, and characterized a new cocrystal of ubiquinol with vitamin B3 nicotinamide (UQ-NC). Compared to the marketed ubiquinol form, the cocrystal exhibited an excellent stability, improved dissolution properties, and higher bioavailability. The cocrystal remained stable for a long period, even when stored under stressed conditions. In the dissolution experiments, the cocrystal generated 12.6 (in SIF) and 38.3 (in SGF) times greater maximum ubiquinol concentrations above that of the marketed form. In addition, in the PK studies, compared to the marketed form, the cocrystal exhibited a 2.2 times greater maximum total coenzyme Q10 concentration and a 4.5 times greater AUC than that of the marketed form. MDPI 2023-10-20 /pmc/articles/PMC10610044/ /pubmed/37896258 http://dx.doi.org/10.3390/pharmaceutics15102499 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhang, Qi Xia, Mengyuan Zheng, Chenxuan Yang, Yinghong Bao, Junjie Dai, Wenjuan Mei, Xuefeng The Cocrystal of Ubiquinol: Improved Stability and Bioavailability |
title | The Cocrystal of Ubiquinol: Improved Stability and Bioavailability |
title_full | The Cocrystal of Ubiquinol: Improved Stability and Bioavailability |
title_fullStr | The Cocrystal of Ubiquinol: Improved Stability and Bioavailability |
title_full_unstemmed | The Cocrystal of Ubiquinol: Improved Stability and Bioavailability |
title_short | The Cocrystal of Ubiquinol: Improved Stability and Bioavailability |
title_sort | cocrystal of ubiquinol: improved stability and bioavailability |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610044/ https://www.ncbi.nlm.nih.gov/pubmed/37896258 http://dx.doi.org/10.3390/pharmaceutics15102499 |
work_keys_str_mv | AT zhangqi thecocrystalofubiquinolimprovedstabilityandbioavailability AT xiamengyuan thecocrystalofubiquinolimprovedstabilityandbioavailability AT zhengchenxuan thecocrystalofubiquinolimprovedstabilityandbioavailability AT yangyinghong thecocrystalofubiquinolimprovedstabilityandbioavailability AT baojunjie thecocrystalofubiquinolimprovedstabilityandbioavailability AT daiwenjuan thecocrystalofubiquinolimprovedstabilityandbioavailability AT meixuefeng thecocrystalofubiquinolimprovedstabilityandbioavailability AT zhangqi cocrystalofubiquinolimprovedstabilityandbioavailability AT xiamengyuan cocrystalofubiquinolimprovedstabilityandbioavailability AT zhengchenxuan cocrystalofubiquinolimprovedstabilityandbioavailability AT yangyinghong cocrystalofubiquinolimprovedstabilityandbioavailability AT baojunjie cocrystalofubiquinolimprovedstabilityandbioavailability AT daiwenjuan cocrystalofubiquinolimprovedstabilityandbioavailability AT meixuefeng cocrystalofubiquinolimprovedstabilityandbioavailability |